Clinical trial

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small…

NCT00002858 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status

Key facts

NCT number NCT00002858
Title Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
Official title PHASE III STUDY COMPARING TWO DOSES OF INDUCTION CHEMOTHERAPY FOLLOWED BY ALTERNATION OF CHEMOTHERAPY AND RADIOTHERAPY IN LIMITED SMALL CELL LUNG CANCER
Lead sponsor Gustave Roussy, Cancer Campus, Grand Paris, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Radiation
Interventions cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, radiation therapy
Enrollment 280
Start date Mar 1, 1993
First posted Mar 12, 2004
Last update posted Feb 9, 2009
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies